Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease

Basic Research in Cardiology

Volumn 91, Issue 3, 1996, Pages 248-255

  Moreno Jr , H ^a   Metze, K ^a   Bento, A C ^a   Antunes, E ^a   Zatz, R ^b   De Nucci, G ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arterial hypertension; Endothelium; L NAME; Left ventricular hypertrophy; Myocardial ischemia

Indexed keywords

ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME INHIBITION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MICROSCOPY; NONHUMAN;

ANALYSIS OF VARIANCE; ANIMALS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HYPERTENSION; MALE; MYOCARDIAL ISCHEMIA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 8944253293     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00788911     Document Type: Article

References (25)

1. Amrani M, O'Shea J, Allen NJ, Harding SE, Jayakumar J, Pepper JR, Moncada S (1992) Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol 456: 681-687
2. Arnal JF, Warin L, Michel JB (1992) Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90: 647-652
3. Arnal J-F, El Amrani A-I, Chatelier G, Ménard J, Michel J-B (1993) Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387
4. Baylis C, Mitruka B, Deng A (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281
5. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364
6. Carlton WW, Engelhardt JA (1991) Poliarterites, rat. In: Jones TC, Mohr U, Hunt RD, eds. Cardiovascular and Musculoskeletal Systems. Berlin: Springer-Verlag: 71-76
7. Dussaule JC, Michel JB, Auzan K, Schwarte P, Corvol, Menard J (1986) Effect of antihypertensive treatment on the left ventricular isomyosin profile in one-clip, two kidney hypertensive rats. J Pharmacol Exp Ther 236: 512-518
8. Fein FS, Cho S, Zola BE, Miller B, Factor SM (1989) Cardiac pathology in the hypertensive diabetic rat. Am J Pathol 134: 1159-1166
9. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol 101: 746-752
10. Gascho J, Mueller TM, Eastham CL, Muiesan ML (1982) Abnormalities of the coronary circulation in normotensive dogs with volume-induced left ventricular hypertrophy. Cardiovasc Res 16: 288-292
11. Goldblatt H, Lynch J, Hanzal RF, Summerville WW (1934) Studies on experimental hypertension. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59: 347-379
12. Hammond JW, Devereux RB, Alderman MH, Laragh JH (1988) Relation of blood pressure and body build to left ventriclar mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 12: 996-1004
13. Houghton JL, Frank MJ, Carr AA, Von Dohlen TW, Prisant LM (1990) Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 15: 43-51
14. Hultgren PB, Boye AA (1978) Myocardial blood flow at rest and during exercise in dogs with volume overload induced left ventricular hypertrophy. Fed Proc 37: 647-649
15. Jover B, Herizi A, Ventre F, Dupont M, Mimran A (1993) Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 21: 944-948
16. Kerns WD, Joseph EC, Morgan G (1991) Drug-induced lesions, arteries, rat. In: Jones TC, Mohr U, Hunt RD, eds. Cardiovascular and Musculoskleletal Systems. Berlin: Springer-Verlag: 76-83
17. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352
18. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP (1989) Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Intern Med 108: 7-13
19. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 332: 1561-1566
20. G-Nitroarginine (NOARG) inhibits endothelium-dependent vasodilatation in the rabbit aorta and perfused rat mesentery. Br J Pharmacol 176: 219-223
21. Radomski MW, Palmer RMJ, Moncada S (1987) Endogenous nitricoxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057-1058
22. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298-303
23. Sasayama S, Franklin D, Ross J Jr (1976) Dynamic changes in left ventricular wall thickness and their use in analyzing function in the conscious dog. Am J Cardiol 38: 870-879
24. Vanhoutte PM, Shimokawa H (1989) Endothelium-derived relaxing factor and coronary vasospasm. Circulation 80: 1-9
25. Zatz R (1990) A low cost tail-cuff method for the estimation of mean arterial pressure in conscious rats. Lab Animal Sci 40: 198-201